• linkedin
  • Increase Font
  • Sharebar

    The 5 Latest FDA Drug Approvals

    The FDA has already approved 24 new drugs in 2017.

     

    Tremfya

    TREMFYA (guselkumab), Janssen

    Indications: Treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.

    Dosage: Injection: Subcutaneous injection, 100 mg/mL in a single-dose prefilled syringe.

    Contraindications: None.

    Read the full label here

    Previous Button

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available